This project has been flagged by a community member as inappropriate due to reason below.*

Survey

Slingshot members are conducting a survey! The topic is:

Quarterly Survey: Benign Prostatic Hyperplasia (BPH) procedures July 2024

Ticker(s): PRCT, TFX, ISRG, JNJ

Who's being surveyed?

Survey results include 20 Urologists.

Survey Questions
Q1.

How many benign prostatic hyperplasia (BPH) procedures do you perform per month, on average?

Q2.

How would you best describe your practice?

  • Academic
  • Community
  • Other

Q3.

How many BPH procedures per month did you perform/do you expect to perform in 2023, 2024, 2025?

Q4.

For patients with prostates <80 g, what proportion of surgical procedures did you perform/do you expect to perform with each procedure?

  • TURP
    • 2023, 2024, 2025

Q5.

For patients with prostates <80 g, what proportion of surgical procedures did you perform/do you expect to perform with each procedure?

  • UroLift
    • 2023, 2024, 2025

Q6.

For patients with prostates <80 g, what proportion of surgical procedures did you perform/do you expect to perform with each procedure?

  • Rezum
    • 2023, 2024, 2025

Q7.

For patients with prostates <80 g, what proportion of surgical procedures did you perform/do you expect to perform with each procedure?

  • Greenlight
    • 2023, 2024, 2025

Q8.

For patients with prostates <80 g, what proportion of surgical procedures did you perform/do you expect to perform with each procedure?

  • HoLEP
    • 2023, 2024, 2025

Q9.

For patients with prostates <80 g, what proportion of surgical procedures did you perform/do you expect to perform with each procedure?

  • Aquablation
    • 2023, 2024, 2025

Q10.

For patients with prostates <80 g, what proportion of surgical procedures did you perform/do you expect to perform with each procedure?

  • Other, specify
    • 2023, 2024, 2025

Q11.

For patients with prostates >= 80g, what proportion of surgical procedures did you perform/do you expect to perform on these patients?

  • Simple prostatectomy
    • 2023, 2024, 2025

Q12.

For patients with prostates >= 80g, what proportion of surgical procedures did you perform/do you expect to perform on these patients?

  • Robotic simple prostatectomy (Da Vinci)
    • 2023, 2024, 2025

Q13.

For patients with prostates >= 80g, what proportion of surgical procedures did you perform/do you expect to perform on these patients?

  • HoLEP
    • 2023, 2024, 2025

Q14.

For patients with prostates >= 80g, what proportion of surgical procedures did you perform/do you expect to perform on these patients?

  • Aquablation
    • 2023, 2024, 2025

Q15.

For patients with prostates >= 80g, what proportion of surgical procedures did you perform/do you expect to perform on these patients?

  • Other, specify
    • 2023, 2024, 2025

Q16.

Please elaborate on your response above.

Q17.

How would you describe the relative safety and efficacy of Aquablation compared with other BPH procedures? Please be specific.

Q18.

How many Aquablation procedures do you expect to perform in the following timeframes?

  • 2023, 2024, 2025

Q19.

How many Urolift procedures do you expect to perform in the following timeframes?

  • 2023, 2024, 2025

Q20.

Has the FDA approval of Intuitive Surgical's da Vinci SP for BPH impacted the number of patients that undergo simple prostatectomy? Why or why not? Please be specific.

Q21.

How often do patients refuse to undergo TURP (or other procedures) due to concerns over sexual side effects? Please elaborate.

Q22.

If your center does not currently have an Aquablation system, does your center plan to acquire the Aquablation system in the next 12 months?

Q23.

In your opinion, how have advancements in BPH technology affected the overall landscape of urological practices? Please be specific.

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.